Researchers have been looking for new blood markers of HCC, such as AFP-L3, DCP and SCCA [24], and have evaluated serum metabolism during the progression from CHB to HCC [10, 11], but they have not been widely used. The gene discussed is AFP; the disease is hepatocellular carcinoma.